Annual Current Liabilities
$6.74 M
-$322.00 K-4.56%
December 31, 2023
Summary
- As of February 23, 2025, TOVX annual total current liabilities is $6.74 million, with the most recent change of -$322.00 thousand (-4.56%) on December 31, 2023.
- During the last 3 years, TOVX annual current liabilities has risen by +$3.77 million (+127.17%).
- TOVX annual current liabilities is now -65.90% below its all-time high of $19.76 million, reached on December 1, 2016.
Performance
TOVX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$7.32 M
+$475.00 K+6.94%
September 1, 2024
Summary
- As of February 23, 2025, TOVX quarterly total current liabilities is $7.32 million, with the most recent change of +$475.00 thousand (+6.94%) on September 1, 2024.
- Over the past year, TOVX quarterly current liabilities has stayed the same.
- TOVX quarterly current liabilities is now -71.28% below its all-time high of $25.50 million, reached on June 1, 2015.
Performance
TOVX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TOVX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.6% | 0.0% |
| 3 y3 years | +127.2% | 0.0% |
| 5 y5 years | +99.1% | 0.0% |
TOVX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.6% | +89.6% | -44.8% | +106.0% |
| 5 y | 5-year | -4.6% | +127.2% | -44.8% | +249.1% |
| alltime | all time | -65.9% | +3269.0% | -71.3% | -100.0% |
Theriva Biologics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.32 M(+6.9%) |
| Jun 2024 | - | $6.85 M(+14.0%) |
| Mar 2024 | - | $6.01 M(-10.8%) |
| Dec 2023 | $6.74 M(-4.6%) | $6.74 M(-22.9%) |
| Sep 2023 | - | $8.74 M(-4.3%) |
| Jun 2023 | - | $9.13 M(+6.0%) |
| Mar 2023 | - | $8.62 M(+22.1%) |
| Dec 2022 | $7.06 M(+98.6%) | $7.06 M(-46.5%) |
| Sep 2022 | - | $13.19 M(-0.5%) |
| Jun 2022 | - | $13.26 M(+20.8%) |
| Mar 2022 | - | $10.98 M(+208.8%) |
| Dec 2021 | $3.55 M(+19.8%) | - |
| Dec 2021 | - | $3.55 M(+12.5%) |
| Sep 2021 | - | $3.16 M(+50.6%) |
| Jun 2021 | - | $2.10 M(-1.1%) |
| Mar 2021 | - | $2.12 M(-28.5%) |
| Dec 2020 | $2.97 M(-43.8%) | $2.97 M(-1.5%) |
| Sep 2020 | - | $3.01 M(-12.2%) |
| Jun 2020 | - | $3.43 M(+19.2%) |
| Mar 2020 | - | $2.88 M(-45.5%) |
| Dec 2019 | $5.28 M(+55.9%) | $5.28 M(-6.4%) |
| Sep 2019 | - | $5.63 M(+47.8%) |
| Jun 2019 | - | $3.81 M(+28.7%) |
| Mar 2019 | - | $2.96 M(-12.5%) |
| Dec 2018 | $3.38 M(-65.4%) | $3.38 M(-13.5%) |
| Sep 2018 | - | $3.91 M(-9.4%) |
| Jun 2018 | - | $4.32 M(-15.1%) |
| Mar 2018 | - | $5.09 M(-48.1%) |
| Dec 2017 | $9.79 M(-50.4%) | $9.79 M(-44.1%) |
| Sep 2017 | - | $17.52 M(+42.1%) |
| Jun 2017 | - | $12.33 M(-25.2%) |
| Mar 2017 | - | $16.49 M(-16.5%) |
| Dec 2016 | $19.76 M(+26.9%) | $19.76 M(+41.0%) |
| Sep 2016 | - | $14.01 M(-7.7%) |
| Jun 2016 | - | $15.17 M(-13.4%) |
| Mar 2016 | - | $17.53 M(+12.5%) |
| Dec 2015 | $15.57 M(+62.4%) | $15.57 M(-10.0%) |
| Sep 2015 | - | $17.30 M(-32.1%) |
| Jun 2015 | - | $25.50 M(+66.2%) |
| Mar 2015 | - | $15.34 M(+60.0%) |
| Dec 2014 | $9.59 M(+833.6%) | $9.59 M(+874.4%) |
| Sep 2014 | - | $984.00 K(-20.1%) |
| Jun 2014 | - | $1.23 M(+59.4%) |
| Mar 2014 | - | $773.00 K(-24.7%) |
| Dec 2013 | $1.03 M(+160.0%) | $1.03 M(+75.9%) |
| Sep 2013 | - | $584.00 K(+155.0%) |
| Jun 2013 | - | $229.00 K(+16.8%) |
| Mar 2013 | - | $196.00 K(-50.4%) |
| Dec 2012 | $395.00 K(-5.3%) | $395.00 K(-5.3%) |
| Sep 2012 | - | $417.00 K(+5.6%) |
| Jun 2012 | - | $395.00 K(-10.8%) |
| Mar 2012 | - | $443.00 K(+6.2%) |
| Dec 2011 | $417.00 K(-16.6%) | $417.00 K(+78.2%) |
| Sep 2011 | - | $234.00 K(-41.2%) |
| Jun 2011 | - | $397.90 K(-66.4%) |
| Mar 2011 | - | $1.18 M(+136.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $500.00 K(+17.5%) | $500.00 K(+50.7%) |
| Sep 2010 | - | $331.80 K(-40.7%) |
| Jun 2010 | - | $559.70 K(+55.6%) |
| Mar 2010 | - | $359.60 K(-15.5%) |
| Dec 2009 | $425.60 K(-31.4%) | $425.60 K(+55.4%) |
| Sep 2009 | - | $273.90 K(-39.4%) |
| Jun 2009 | - | $452.10 K(-30.1%) |
| Mar 2009 | - | $647.10 K(+4.3%) |
| Dec 2008 | $620.70 K(-63.2%) | $620.70 K(-8.3%) |
| Sep 2008 | - | $677.00 K(-17.1%) |
| Jun 2008 | - | $816.20 K(-38.0%) |
| Mar 2008 | - | $1.32 M(-21.9%) |
| Dec 2007 | $1.69 M(+131.5%) | $1.69 M(+45.5%) |
| Sep 2007 | - | $1.16 M(-9.5%) |
| Jun 2007 | - | $1.28 M(+72.8%) |
| Mar 2007 | - | $741.90 K(+1.8%) |
| Dec 2006 | $729.00 K(-66.0%) | $729.00 K(>+9900.0%) |
| Sep 2006 | - | $3000.00(>+9900.0%) |
| Jun 2006 | - | $0.00(-100.0%) |
| Mar 2006 | - | $9400.00(-99.8%) |
| Dec 2005 | $2.14 M(-57.3%) | - |
| Mar 2003 | - | $5.43 M(+8.2%) |
| Dec 2002 | $5.02 M(-9.2%) | $5.02 M(+44.2%) |
| Sep 2002 | - | $3.48 M(+21.1%) |
| Jun 2002 | - | $2.88 M(+16.8%) |
| Mar 2002 | - | $2.46 M(-55.5%) |
| Dec 2001 | $5.53 M(+276.3%) | $5.53 M(+73.4%) |
| Sep 2001 | - | $3.19 M(+74.3%) |
| Jun 2001 | - | $1.83 M(+70.1%) |
| Mar 2001 | - | $1.08 M(-26.8%) |
| Dec 2000 | $1.47 M(+23.1%) | $1.47 M(+78.3%) |
| Sep 2000 | - | $824.90 K(-3.8%) |
| Jun 2000 | - | $857.30 K(-6.7%) |
| Mar 2000 | - | $918.90 K(-23.1%) |
| Dec 1999 | $1.19 M(-0.4%) | $1.19 M(-25.3%) |
| Sep 1999 | - | $1.60 M(+60.0%) |
| Jun 1999 | - | $1.00 M(-9.1%) |
| Mar 1999 | - | $1.10 M(-8.3%) |
| Dec 1998 | $1.20 M(-14.3%) | $1.20 M(+20.0%) |
| Sep 1998 | - | $1.00 M(-16.7%) |
| Jun 1998 | - | $1.20 M(-61.3%) |
| Mar 1998 | - | $3.10 M(+121.4%) |
| Dec 1997 | $1.40 M(+27.3%) | $1.40 M(+27.3%) |
| Sep 1997 | - | $1.10 M(+22.2%) |
| Jun 1997 | - | $900.00 K(-40.0%) |
| Mar 1997 | - | $1.50 M(+36.4%) |
| Dec 1996 | $1.10 M(+175.0%) | $1.10 M(+57.1%) |
| Sep 1996 | - | $700.00 K(-12.5%) |
| Jun 1996 | - | $800.00 K(+100.0%) |
| Mar 1996 | - | $400.00 K(0.0%) |
| Dec 1995 | $400.00 K(-55.6%) | $400.00 K(0.0%) |
| Sep 1995 | - | $400.00 K(-55.6%) |
| Dec 1994 | $900.00 K(+350.0%) | $900.00 K(+350.0%) |
| Mar 1994 | - | $200.00 K(0.0%) |
| Dec 1993 | $200.00 K | $200.00 K(0.0%) |
| Jun 1993 | - | $200.00 K(-77.8%) |
| Mar 1993 | - | $900.00 K |
FAQ
- What is Theriva Biologics annual total current liabilities?
- What is the all time high annual current liabilities for Theriva Biologics?
- What is Theriva Biologics annual current liabilities year-on-year change?
- What is Theriva Biologics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Theriva Biologics?
- What is Theriva Biologics quarterly current liabilities year-on-year change?
What is Theriva Biologics annual total current liabilities?
The current annual current liabilities of TOVX is $6.74 M
What is the all time high annual current liabilities for Theriva Biologics?
Theriva Biologics all-time high annual total current liabilities is $19.76 M
What is Theriva Biologics annual current liabilities year-on-year change?
Over the past year, TOVX annual total current liabilities has changed by -$322.00 K (-4.56%)
What is Theriva Biologics quarterly total current liabilities?
The current quarterly current liabilities of TOVX is $7.32 M
What is the all time high quarterly current liabilities for Theriva Biologics?
Theriva Biologics all-time high quarterly total current liabilities is $25.50 M
What is Theriva Biologics quarterly current liabilities year-on-year change?
Over the past year, TOVX quarterly total current liabilities has changed by $0.00 (0.00%)